{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Potentially Fatal Side Effect of ACE Inhibitors: Angioedema
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
This article discusses angioedema, a serious side effect of ACE inhibitors. Three articles are reviewed: one on the management of angioedema in the emergency department, one on the use of fresh frozen plasma for the treatment of angioedema, and one on the efficacy of icatibant in angioedema.The article provides an overview on ACEI angioedema. Management of this condition includes anti-allergy medications (e.g,. epinephrine, antihistamines, and corticosteroids), fresh frozen plasma, and icatibant; and intubation and cricothyrotomy. Method of Participation in the Learning Process/Evaluation Method Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form. Getting the Most out of the Activity As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed. While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.Purpose of Activity
To provide information about the symptoms and management of ACEI angioedema.Learning Objectives
After completing this continuing education activity you will be able to:
- Describe and assess the side effects of ACE inhibitors for patients with angioedema.
- Describe and assess the benefits and limitations of various interventions for patients with angioedema.
Disclosures
All faculty members and LCMEI staff members in a position to control the content of this CME activity have disclosed that they and their spouse/life partners (if any) have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity.
Dr. Roberts has disclosed that the U.S. Food and Drug Administration has not approved the use of icatibant and ecallantide for treating ACEI angioedema as discussed in this article. Please consult the products' labeling for approved information.
Price:
$10.00
Credits:
- ACCME 1.0 CME
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Physician
Test Code: EMN0314
Published: Mar 2014
Expires: 1/1/2026
Sources:
Emergency Medicine News
Required Passing Score: 7/10 (70%)
Categories:
Emergency Care
Specialties:
Emergency Medicine
Topics:
ACE Inhibitors
,
Allergy
,
Angioedema
,
Antihistamines
,
Corticosteroids
,
Epinephrine
,
Fresh Frozen Plasma
,
Hypertension
,
Intubation